Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

G Fätkenheuer, AL Pozniak, MA Johnson… - Nature medicine, 2005 - nature.com
We assessed the efficacy and safety of 10-d monotherapy with the orally administered
CCR5 antagonist maraviroc in 63 HIV-1-positive individuals prescreened for the absence of …

Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals

ZL Brumme, J Goodrich, HB Mayer… - The Journal of …, 2005 - academic.oup.com
Objective We wished to characterize the epidemiological and clinical correlates of CXCR4-
using human immunodeficiency virus type 1 (HIV-1)(“X4 variants”) in a cross-sectional …

Pharmacogenomics and the drug discovery pipeline: when should it be implemented?

MA Penny, D McHale - American Journal of PharmacoGenomics, 2005 - Springer
One of the key factors in developing improved medicines lies in understanding the
molecular basis of the complex diseases we treat. Investigation of genetic associations with …

CCR2/64I mutation detection in a HIV-1-positive patient with slow CD4 T-cell decline and delay in disease progression

CT Burton, FM Gotch, N Imami - International journal of STD …, 2005 - journals.sagepub.com
Chemokine receptor genetic mutations are among the factors which have been shown to
influence human susceptibility to HIV-1 infection and progression. The CCR2-64I mutation …

Global human genetics of HIV-1 infection and China

TF Zhu, TJ Feng, X Xiao, H Wang, BP Zhou - Cell research, 2005 - nature.com
Genetic polymorphisms in human genes can influence the risk for HIV-1 infection and
disease progression, although the reported effects of these alleles have been inconsistent …

Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and …

J Eugen-Olsen - US Patent 6,902,884, 2005 - Google Patents
Method of diagnosing and/or prognosticating HIV infection in a Subject comprising the steps
of:(a) performing in vitro a measurement of the level of a marker in the form of (i) urokinase …

[PDF][PDF] Distribuzione delle varianti A32 e 64I dei geni per il CCR5 e il CCR2 in alcune popolazioni del Mediterraneo

IS Piras, L Vacca, CM Calò, A Falchi, ME Ghiani… - Antropo, 2005 - academia.edu
Le varianti dei geni CCR5 e CCR2 sono state messe in relazione con una differente
suscettibilità all'infezione da HIV-1. In particolare, gli individui omozigoti per il CCR5-A32 …

[PDF][PDF] ARN de interferencia y su importancia en la biomedicina molecular

JLH García - Bioquimia, 2005 - redalyc.org
El ARN de interferencia (ARNi) es una conservada respuesta biológica a la presencia de
ARN de doble cadena, lo cual origina el silenciamiento específico de secuencia de un gen …

RNA interference: its role in the molecular biomedicine

JL Hernández-García - Bioquimia, 2005 - medigraphic.com
ABSTRACT ARN interference (RNAi) is a conserved biological response to double-stranded
RNA that results in the sequence-specific silencing of target gene expression. Over the past …